bioGenous Biotechnology
PrivateLast Round
Series A
Extension
Dec 31, 2024
Total Funding Raised
$14.7M
Company Overview
bioGenous Biotechnology is a biotechnology company that specializes in organoid construction, drug testing, and multi-omics analysis, providing standardized organoid products and integrated technical services for the biopharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
bioGenous Biotechnology Comparables
Compare bioGenous Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| K2 Oncology | 87% | |
| AimingMed | 87% | |
| Accurate International Biotechnology | 84% | |
bioGenous Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 31, 2024 | ||||
| Series A | Jan 5, 2023 | ||||
| Early Funding | Oct 14, 2022 | ||||
| Angel | Aug 10, 2021 |
bioGenous Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SDIC Fund Management | Series A |
| Marathon Venture Partners | Series A, Early Funding |
| 源创多盈投资 | Early Funding, Angel |
| CICC Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 31, 2024
Led by CICC Capital
- Jan 5, 2023
$15M round led by SDIC Fund Management.
bioGenous Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about bioGenous Biotechnology's valuation, stock price, and market status.